HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Revised US FDA Guidance Calls For Testing More Excipients For DEG And EG

Executive Summary

Substantial revision of 2007 DEG guidance comes after hundreds of deaths in seven countries inked to diethylene glycol and ethylene glycol adulteration. All containers and lots of certain additional excipients must be tested, and many others should be.

You may also be interested in...

US FDA Warns NJ Firm On Drug And Supplement GMPs, Indian Firm On Diethylene Glycol Testing

Agency’s latest posting of warning letters submitted also includes more warnings about OTC hand sanitizer production failing to meet GMP requirements.

The Quality Lowdown: The Effort Required To Stem Substandard, Illegitimate, Unapproved Drugs

As stakeholders in the US pharmaceutical distribution chain prepare to coordinate against suspect drugs, the world’s leading inspectorates collaborate on good distribution practices.

Updated USP Glycerin Standard Should Prevent Product Adulteration

A revised testing protocol from U.S. Pharmacopeia should help prevent adulterated glycerin, an ingredient in toothpastes, from entering the U.S. supply chain

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts